(Q43240839)

17 November 2017

Potential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1. (English)

1 reference

17 November 2017

2

Lisa M Frenkel

1 reference

17 November 2017

Thor A Wagner

1

1 reference

PMCID

2585823

17 November 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

17 November 2017

1 reference

17 November 2017

22

1 reference

17 November 2017

17

1 reference

17 November 2017

2393-2395

1 reference

Update of the drug resistance mutations in HIV-1: 2007.

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585823

Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585823

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585823

Predicting HIV-1 coreceptor usage with sequence analysis.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585823

Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585823

10.1097/QAD.0B013E328312C72C

25 May 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference

17 November 2017

1 reference

PMCID

2585823